Sitero Expands Clinical AI Across the Data Lifecycle
Coral Gables, Florida, August 18, 2026 Sitero, a global clinical research organization (CRO) and clinical technology company, has announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Coral Gables, Florida, August 18, 2026 Sitero, a global clinical research organization (CRO) and clinical technology company, has announced...
DUBLIN, Ireland, August 18, 2026 Cumulus Neuroscience has announced publication of final results from its CNS-102 study in Scientific...
MENLO PARK, Calif., August 18, 2026 BillionToOne, Inc., a molecular diagnostics company developing quantitative genetic testing technologies, has announced...
BOSTON, August 18, 2026 Curavit Clinical Research, a next-generation clinical research organization (CRO) and Remote Clinical Site, announced the...
ST. PAUL, Minnesota, August 11, 2026 Egg Medical, Inc., a medical technology company focused on radiation protection for healthcare...
WALNUT CREEK, California & SHANGHAI, China, August 11, 2026 Dark Horse Consulting Group (DHCG), a life sciences consulting organization...
DUBLIN, Ireland, July 28, 2026 DUBLIN, Ireland, July 28, 2026 – ICON plc announced a multi-year strategic collaboration with...
BOSTON, July 27, 2026 HoneyNaps has officially registered as a Contract Research Organization (CRO) with the Korea National Enterprise...
WEST PALM BEACH, Fla., and SACRAMENTO, Calif., June 30, 2026 Headlands Research announced the acquisition of Clinical Trials Research...
BAAR, Switzerland, June 30, 2026 Novocure has achieved a significant milestone in cancer treatment with the CE Mark approval...
